Aurigon, established in 2000, is an independent, privately-owned contract research institute dedicated to preclinical services for human and veterinary pharmaceuticals, food and chemicals.
Aurigon provides a full range of advisory and experimental services in pharmacology, bio-/analytics and toxicology. Ranging from early-phase product efficacy and safety evaluation to regulatory toxicology and late-stage pre-marketing testing, we cover all areas of non-clinical drug development. Aurigon is a trusted outsourcing partner for multinational pharmaceutical and chemical groups, food producers and dynamic biotechnology companies.
With its international headquarters in Munich, Aurigon operates state-of-the-art GLP- and/or GMP-compliant facilities at its ATRC Aurigon Toxicological Research Center near Budapest.
For us at AURIGON, quality means more than just working in GLP/GMP-certified testing facilities and laboratories. We don’t think in quality categories – all studies, whether exploratory experiments or regulatory studies, are embedded in our GLP-regulated quality assurance system.
Pillars of this system are:
Day by day, our staff demonstrate that this system delivers a maximum of flexibility and scientific expertise to support our customers in achieving their goals. Proactive communication with our clients results in tailor-made solutions ranging from the conception of study packages and study designs, via the complete performance of the studies to the interpretation of results and their possible consequences. Our goal is to take our clients ...
... a wing stroke ahead.